Duralactin Canine for Long Term Management of Chronic Inflammatory Conditions in Dogs.
Duralactin contains MicroLactin, a patented dried milk protein from the milk of hyperimmunized cows. Numerous peer-reviewed research publications have demonstrated significant effects of MicroLactin in arthritis and other inflammatory conditions.
Duralactin is a natural product derived from milk that can help your companion live a comfortable and active life.
Other products in the line include:
Duralactin® Canine Joint Plus Soft Chew
Duralactin Canine for Long Term Management of Chronic Inflammatory Conditions in Dogs.
For the long term management of chronic inflammation. Helps support normal activity and wellness.
Active ingredient, MicroLactin® dried milk protein, appears to block cytokines to inhibit neutrophil participation in the inflammatory response.
- Results seen in 4-7 days with peak effects in 10-14 days
- Does not suppress immune system*
- Duralactin® Canine chewable tablets are palatable vanilla flavored
- Duralactin® Canine & Feline Liquid with
Omega 6 and Omega 3 fatty acids for small to medium size dogs
Duralactin Canine for Long Term Management of Chronic Inflammatory Conditions in Dogs.
| Every effort has been made to ensure the accuracy of the information published. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert. |
DURALACTIN® CANINE
V.P.L.
For Long Term Management of Chronic Inflammatory Conditions in Dogs
Product Facts
Active Ingredient per tablet:
|
MicroLactin® (dried milk protein) |
1000 mg |
Dextrose, magnesium stearate, stearic acid, vanilla flavoring.
If animal’s condition worsens or does not improve, stop product administration and consult your veterinarian.
Recommended for long term management of chronic inflammatory conditions.
DURALACTIN® Canine contains MicroLactin®, a patented dried milk protein concentrate derived from hyperimmunized cows that contains factors that appear to block cytokines and inhibit neutrophil participation in the inflammatory response.*
DURALACTIN® Canine does not share the mechanism of action of any known drug and is not a cyclooxygenase (COX-1 or COX-2) inhibitor.
*Data on file.
Feed directly or give with food.
|
Weight of Dog |
Dosage |
|
<40 lbs. |
1/2 tablet twice daily |
|
40 - 80 lbs. |
1 tablet twice daily |
|
81 - 120 lbs. |
1 1/2 tablets twice daily |
For use in dogs only.
Keep out of the reach of other animals and children. In case of accidental overdose, contact a health professional immediately.
Manufactured for: Veterinary Products Laboratories, P.O. Box 34820, Phoenix, AZ 85067-4820
www.vpl.com
Call with questions or comments: 1-888-241-9545
MicroLactin is a registered trademark of Stolle Milk Biologics, Inc. (SMBI)
(U.S. patent #s 5,242,691; 5,352,462; 5,650,175; 5,980,953)
©2007, 2008 Veterinary Products Laboratories
|
|
Product Code: |
RM#: |
|
|
60 Chewable Vanilla Flavored Tablets |
3002932 |
300500959 |
07-2563 |
|
180 Chewable Vanilla Flavored Tablets |
3004948 |
300500962 |
07-2564 |
NAC No.: 11430604